COVID-19: Singapore to help develop oral antiviral treatment

Singapore researchers could have a hand in developing an oral antiviral treatment for COVID-19, touted as "potentially best-in-class." The country's Experimental Drug Development Centre (EDDC) has signed a deal with pharma firm Everest Medicines to have what are called protease inhibitors developed into a drug. These inhibitors are molecules that can stop the coronavirus from multiplying. Dr Ang Hwee Ching, EDDC's Deputy CEO, shared more details.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia